In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...

Earlier this month, NICE reiterated its position that Spravato should not be used for TRD, after an appeal of earlier rejections by J&J, with a final decision due in mid-December. In the ESCAPE ...

Johnson & Johnson (J&J) has received US Food and Drug Administration (FDA) approval for its interleukin 23 inhibitor, Tremfya ...

Blessing Outpatient Behavioral Health Services is offering a new option for depression. As many as 40% of people with depression can find no relief for their condition.

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

I've used quite a few of them and can tell you firsthand that some are far more clunky than others. Many will let you try a demo version before committing any money, and if that's the case ...

Myers Squibb Company, Johnson & Johnson, Bausch Health Companies Inc, AbbVie Inc. Read 's Market Analysis on Investing.com ...

Elon Musk discussed his use of ketamine for depression during an interview, claiming it helps him combat negative mental ...

Q4 2024 Earnings Call Transcript March 17, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the NRx ...

Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and full year 2024 earnings call. At this time, all lines are in a listen only mode. Following the presentation, we will ...